News After more encouraging data, Ablynx to file first drug with ... New trial data will be included in US and EU filings
News Ablynx soars after blood clot trial success European regulators are already reviewing caplacizumab
News Ablynx and Sanofi sign potential 2.4bn euro R&D deal Collaboration will develop drugs for inflammatory diseases
News Ablynx in talks with partners for RA drug Biotech suffered setback after AbbVie decided against partnership.
News AbbVie waits on data from Humira successor Ablynx's vobarilizumab seen as key should Humira sales fall.
News Bayer trial combines two top drugs for kidney disease Data from the CONFIDENCE trial shows the value of combining Bayer's Kerendia with an SGLT2 inhibitor to treat chronic kidney disease in diabetics.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face
